Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Weekly market intelligence for operators who need to stay ahead, not catch up
Published every Monday. The Weekly Supplement and Health Lowdown covers the seven to ten most significant market movements from the preceding week across UK, EU, North America, and ANZ.
Each edition covers:
M&A activity and corporate moves - acquisitions, funding rounds, licensing deals, and distribution partnerships with a direct read on what they signal for category direction.
Protein pricing and commodity watch - WPC80, WPI, clear whey, plant proteins, collagen peptides. Current European and US pricing with directional indicators and supply chain context.
Regulatory radar - EFSA opinions, FSA updates, Novel Food developments, MHRA changes, HFSS implications, and EU member-state enforcement actions that will affect your product portfolio.
Product launch pulse - the most strategically relevant new launches from the week, with ingredient detail, pricing, distribution, and positioning rationale.
Consumer and channel intelligence - GLP-1 adoption data, DTC versus retail shift signals, demographic changes, and retailer strategy movements.
The seventy-8 take - a direct editorial read on the week's biggest story and what it means for UK and EU brands. Not balanced. Opinionated. Correct more often than not.
Weekly market intelligence for operators who need to stay ahead, not catch up
Published every Monday. The Weekly Supplement and Health Lowdown covers the seven to ten most significant market movements from the preceding week across UK, EU, North America, and ANZ.
Each edition covers:
M&A activity and corporate moves - acquisitions, funding rounds, licensing deals, and distribution partnerships with a direct read on what they signal for category direction.
Protein pricing and commodity watch - WPC80, WPI, clear whey, plant proteins, collagen peptides. Current European and US pricing with directional indicators and supply chain context.
Regulatory radar - EFSA opinions, FSA updates, Novel Food developments, MHRA changes, HFSS implications, and EU member-state enforcement actions that will affect your product portfolio.
Product launch pulse - the most strategically relevant new launches from the week, with ingredient detail, pricing, distribution, and positioning rationale.
Consumer and channel intelligence - GLP-1 adoption data, DTC versus retail shift signals, demographic changes, and retailer strategy movements.
The seventy-8 take - a direct editorial read on the week's biggest story and what it means for UK and EU brands. Not balanced. Opinionated. Correct more often than not.